Some of my thoughts as I like many of you are shocked with
Some of my thoughts as I like many of you are shocked with how low that this actually got
First nothing has changed as far as the science and as far as the FDA process and as far as getting approval it is all in the hands of the FDA and the doctors replying to the FDA requests
We myself included have artificially put a date or timeline in our minds of when things should should be completed STOP doing this to your self
I can assure everyone after a lot of discussion that I have had recently with those that should know that no one has made any mistake no one has mishandled any issue regarding the FDA process it is just running the course something that is new and something that is different something that will be completed in due time
Regarding the ebola issue what the h....are you people thinking they are staying the course and focused on HEMA and DCELLVAX and Will continue to add products just as they stated from day one anything that can be seen as added value in the gene silencing process will be added to the business model that is already suggested
I Suspect that they'll still be even more to come!!!!
I have asked for projections of next year's goals and new timelines published for us investors as well as keeping things as transparent and giving us frequent updates as to what's going on and David is doing this!!!!
As we are all in this waiting process and there are so many inpatient people due to IHUb I fully hope that David will keep us abreast of issues such as cash and cash requirements new developments grants or outside financing
I too spent a lot of money last week and wished it had waited till this week instead of last week I'm not crying over spilt milk just keeping in sight the opportunity that IS ahead of us and will continue to add as much as I can
Finally David has done exactly what he told us he would I fully suspect that he will continue to do exactly what he says he will do I would highly suggest those that have not read my old post dig them up I have been pretty accurate in outgassing what was going to happen my time why may be off but I've been spot on with what he is done and will do to add investor value !!
Morons will sell and tare down the pps but I assure you David will build this back up again via FDA completion New IND submissions New patents new people and he has already demonstrated his creativity in giving us stock awards for being patient
So quit reading the crap and trust in him just a little as he does deserve that from us now !!!
I could choose to say nothing so I don't care what you say about this post
But for those who care and that are patient I hope this helps
RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...
Continue Reading
Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...
Continue Reading
Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...
Continue Reading
Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...
Continue Reading
Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...
Continue Reading
OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...
Continue Reading
Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...
Continue Reading
Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...
Continue Reading
Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...
Continue Reading
Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...
Continue Reading
Top 5 Most Recently Viewed Articles
Leadership Evolution at Hydro One If change is the only constant in life, Hydro One's latest announcement is a testament to that mantra. Megan Telford, an insider previously on the company's management info circular's shortlist, now ascends as the President and CEO. She comes on board as David Lebeter bids adieu—this isn't just a routine shuffle. It's a repositioning...
Continue Reading
Significant Stake Acquisition in Irish Continental Group In a notable movement within the investment landscape, Wellington Management Group LLP has made headlines by acquiring a significant stake in Irish Continental Group plc. The firm has publicly acknowledged this strategic acquisition of voting rights, indicating its growing stake in a prominent player within the...
Continue Reading
Understanding DTE Energy's Current Market Performance DTE Energy Inc. (NYSE:DTE) is currently trading at a price of $137.00 after seeing a slight increase of 0.18%. Over the past month, the stock has experienced a decrease of 3.46%. However, when looking at the past year's performance, it's clear that the stock has gained 13.89%. Investors are keen to assess whether this...
Continue Reading
Exciting Developments from Corvus Pharmaceuticals on Eczema Treatment Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a revolutionary biopharmaceutical company, has announced some promising interim results regarding its drug, soquelitinib, designed for treating moderate to severe atopic dermatitis, commonly known as eczema. The company, which boasts a market capitalization...
Continue Reading
Overview of Lucid Group Inc Stock Performance Lucid Group Inc (NASDAQ: LCID) shares have shown a stable performance, remaining flat in recent trading sessions. This comes after a significant turbulent period as the electric vehicle maker has been rebounding from a substantial 52-week low of $15.25 experienced in early September. Investors and market watchers alike are...
Continue Reading